Tango Therapeutics Inc (TNGX)
3.90
+0.34
(+9.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.90
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Total Liabilities (Quarterly): 123.24M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 123.24M |
| June 30, 2024 | 133.78M |
| March 31, 2024 | 141.77M |
| December 31, 2023 | 149.46M |
| September 30, 2023 | 151.59M |
| June 30, 2023 | 166.38M |
| March 31, 2023 | 176.51M |
| Date | Value |
|---|---|
| December 31, 2022 | 186.99M |
| September 30, 2022 | 191.08M |
| June 30, 2022 | 149.70M |
| March 31, 2022 | 151.17M |
| December 31, 2021 | 155.41M |
| September 30, 2021 | 164.72M |
| December 31, 2020 | 168.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
123.24M
Minimum
Sep 2024
191.08M
Maximum
Sep 2022
157.89M
Average
153.50M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 352.42M |
| Shareholders Equity (Quarterly) | 229.17M |
| Current Ratio | 8.004 |